These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 3950420

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The major Leishmania donovani chagasi surface glycoprotein in tunicamycin-resistant promastigotes.
    Wilson ME, Hardin KK.
    J Immunol; 1990 Jun 15; 144(12):4825-34. PubMed ID: 2191040
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Infectivity of Leishmania braziliensis promastigotes is dependent on the increasing expression of a 65,000-dalton surface antigen.
    Kweider M, Lemesre JL, Darcy F, Kusnierz JP, Capron A, Santoro F.
    J Immunol; 1987 Jan 01; 138(1):299-305. PubMed ID: 3782801
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Kinetics of entry of virulent and avirulent strains of Leishmania donovani into macrophages: a possible role of virulence molecules (gp63 and LPG).
    Chakrabarty R, Mukherjee S, Lu HG, McGwire BS, Chang KP, Basu MK.
    J Parasitol; 1996 Aug 01; 82(4):632-5. PubMed ID: 8691373
    [Abstract] [Full Text] [Related]

  • 11. Complement receptor type 3 (CR3) binds to an Arg-Gly-Asp-containing region of the major surface glycoprotein, gp63, of Leishmania promastigotes.
    Russell DG, Wright SD.
    J Exp Med; 1988 Jul 01; 168(1):279-92. PubMed ID: 3294332
    [Abstract] [Full Text] [Related]

  • 12. Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of antigens associated with stage- and species-specific determinants.
    Pan AA, McMahon-Pratt D.
    J Immunol; 1988 Apr 01; 140(7):2406-14. PubMed ID: 2450920
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Human T cell responses to gp63, a surface antigen of Leishmania.
    Russo DM, Burns JM, Carvalho EM, Armitage RJ, Grabstein KH, Button LL, McMaster WR, Reed SG.
    J Immunol; 1991 Nov 15; 147(10):3575-80. PubMed ID: 1940356
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increased infectivity of stationary-phase promastigotes of Leishmania donovani: correlation with enhanced C3 binding capacity and CR3-mediated attachment to host macrophages.
    Wozencraft AO, Blackwell JM.
    Immunology; 1987 Apr 15; 60(4):559-63. PubMed ID: 2953670
    [Abstract] [Full Text] [Related]

  • 17. The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes.
    Mosser DM, Edelson PJ.
    J Immunol; 1985 Oct 15; 135(4):2785-9. PubMed ID: 3161950
    [Abstract] [Full Text] [Related]

  • 18. The major surface protein of Leishmania promastigotes is a fibronectin-like molecule.
    Rizvi FS, Ouaissi MA, Marty B, Santoro F, Capron A.
    Eur J Immunol; 1988 Mar 15; 18(3):473-6. PubMed ID: 2965651
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.